Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118475) titled 'Autologous Islet Transplantation for Diabetes' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Shanghai Zhongshan Hospital

Condition: Diabetes (Insulin-requiring, Type 1 or Type 2)

Intervention: Biological: Autologous islet transplantation

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: August 18, 2025

Target Sample Size: 24

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118475

Publish...